Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virpax Pharmaceuticals, Inc. - Common Stock (NQ: VRPX )

0.2395 -0.0056 (-2.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,253,988
Open 0.2401
Bid (Size) 0.2321 (1)
Ask (Size) 0.2448 (9)
Prev. Close 0.2451
Today's Range 0.2225 - 0.2450
52wk Range 0.2225 - 5.480
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks in Tuesday's session
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
Wondering what's happening in today's pre-market session?
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill

Performance

YTD
-36.05%
-36.05%
1 Month
-13.85%
-13.85%
3 Month
-50.10%
-50.10%
6 Month
-68.49%
-68.49%
1 Year
-92.95%
-92.95%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Unusual volume stocks in Friday's session
Via Chartmill
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
Via Benzinga
Friday's session: gap up and gap down stocks
Via Chartmill
Top movers in Friday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals’ $6 Million Follow-On Offering
From Spartan Capital Securities, LLC
Via GlobeNewswire
Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
From Virpax Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Virpax Pharmaceuticals Stock Gaining On Friday?
Via Benzinga
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.